Human Papillomavirus Prevalence in a Population of Women Living in Port-au-Prince and Leogane, Haiti

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Walmer, David K ^a,b   Eder, Paul S ^c,e   Bell, Laura ^c   Salim, Hiam ^c   Kobayashi, Lori ^c,f   Ndirangu, Jackie ^a   Tinfo, Nicole ^a   Castle, Philip E ^d  

^a Family Health Ministries   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Qiagen   (United States)

^d Global Cancer Initiative   (United States)

^e Tunnell Government Services   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONCURRENT SEXUAL PARTNERSHIP; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HAITI; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 35; MAJOR CLINICAL STUDY; MARRIAGE; PARITY; POPULATION RESEARCH; PREVALENCE; RELIGION; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HAITI; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS;

EID: 84884836856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076110     Document Type: Article

References (29)

1. Mitacek EJ, St Vallieres D, Polednak AP, (1986) Cancer in Haiti 1979-84: distribution of various forms of cancer according to geographical area and sex. Int J Cancer 38: 9-16. doi:10.1002/ijc.2910380103. PubMed: 3721625.
2. Farley J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008: cancer incidence and mortality worldwide.
3. Arrossi S, Sankaranarayanan R, Parkin DM, (2003) Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex, 45 (Suppl 3):: 45:S306-14.: S306-S314 PubMed: 14746023.
4. Dürst M, Gissmann L, Ikenberg H, Zur HH, (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 80: 3812-3815. doi:10.1073/pnas.80.12.3812. PubMed: 6304740.
5. Gissmann L, Pfister H, Zur HH, (1977) Human papilloma viruses (HPV): characterization of four different isolates. Virology 76: 569-580. doi:10.1016/0042-6822(77)90239-2. PubMed: 65825.
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907. doi:10.1016/S0140-6736(07)61416-0. PubMed: 17826171.
7. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, et al. (2012) Global burden of human papillomavirus and related diseases. Vaccine 30 (Suppl 5):: F12-F23. doi:10.1016/j.vaccine.2012.07.055. PubMed: 23199955.: F12-F23.
8. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et.al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056. doi:10.1016/S1470-2045(10)70230-8. PubMed: 20952254.
9. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, et al. (2005) Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 14: 2191-2199. doi:10.1158/1055-9965.EPI-05-0231. PubMed: 16172231.
10. Adegoke O, Kulasingam S, Virnig B, (2012) Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt) 21: 1031-1037. doi:10.1089/jwh.2011.3385.
11. Zandberg DP, Bhargava R, Badin S, Cullen KJ, (2013) The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 63: 57-81. doi:10.3322/caac.21167. PubMed: 23258613.
12. Nazarenko I, Kobayashi L, Giles J, Fishman C, Chen G, et al. (2008) A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP. J Virol Methods 154: 76-81. doi:10.1016/j.jviromet.2008.09.002. PubMed: 18835300.
13. Eklund C, Zhou T, Dillner J, (2010) Global proficiency study of human papillomavirus genotyping. J Clin Microbiol 48: 4147-4155. doi:10.1128/JCM.00918-10. PubMed: 20844222.
14. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, et al. (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 20;97:: 1072-1079.
15. Cuzick J, (1985) A Wilcoxon-type test for trend. Stat Med 4: 87-90. doi:10.1002/sim.4780040112. PubMed: 3992076.
16. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, et al. (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in guanacaste, costa rica. J Infect Dis 191: 1796-1807. doi:10.1086/428850. PubMed: 15871111.
17. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, et al. (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119: 2677-2684. doi:10.1002/ijc.22241. PubMed: 16991121.
18. Almonte M, Ferreccio C, Gonzales M, Delgado JM, Buckley CH, et al. (2011) Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer 21: 1654-1663. doi:10.1097/IGC.0b013e3182288104. PubMed: 21892094.
19. Lazcano-Ponce E, Lorincz AT, Salmeron J, Fernandez I, Cruz A, et al. (2010) A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. Cancer Causes Control 21: 1693-1700. doi:10.1007/s10552-010-9598-2. PubMed: 20617376.
20. Valles X, Murga GB, Hernandez G, Sabido M, Chuy A, et al. (2009) High prevalence of human papillomavirus infection in the female population of Guatemala. Int J Cancer 125: 1161-1167. doi:10.1002/ijc.24444. PubMed: 19415744.
21. Kobetz E, Kish JK, Campos NG, Koru-Sengul T, Bishop I, et al. (2012) Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action. J Oncol: pp. 2012:728397. Epub;%2012 Mar 15.: 728397.
22. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, et al. (2009) Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101: 475-487. doi:10.1093/jnci/djn510. PubMed: 19318628.
23. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE, (2010) Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 19: 1675-1681. doi:10.1158/1055-9965.EPI-10-0251. PubMed: 20615885.
24. Porras C, Rodriguez AC, Hildesheim A, Herrero R, Gonzalez P, et al. (2009) Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev 18: 863-865. doi:10.1158/1055-9965.EPI-08-0951. PubMed: 19273486.
25. Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, et al. (2010) Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev 19: 2389-2400. doi:10.1158/1055-9965.EPI-10-0131. PubMed: 20826836.
26. Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, et al. (2013) Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infect Dis 13: 114. doi:10.1186/1471-2334-13-114. PubMed: 23452957.: 114-13.
27. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, et al. (2004) Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 191: 430-434. doi:10.1016/j.ajog.2004.02.065. PubMed: 15343217.
28. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, et al. (2006) Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 108: 264-272. doi:10.1097/01.AOG.0000220505.18525.85. PubMed: 16880294.
29. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, et al. (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30 (Suppl 5):: F88-F99. doi:10.1016/j.vaccine.2012.06.095. PubMed: 23199969.: F88-F99.